In Blow To Barr Pharma, Appeals Court Affirms Wyeth Victory In Trade-Secrets Case

Law360, New York (January 25, 2005, 12:00 AM EST) -- The U.S. Court of Appeals for the Eighth Circuit has upheld a lower court’s determination that Natural Biologics misappropriated trade secrets from drug maker Wyeth for a hormone replacement treatment, dealing a blow to generic maker Barr Pharma’s attempts to make a generic version of the drug Premarin.

A three-judge panel from the appeals court agreed with the September 2003 decision by the U.S. District Court for the District of Minnesota that Natural Biologics misappropriated trade secrets related to Wyeth's chemical process for extracting estrogens used...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.